Výsledky vyhledávání

Akademický článek

Comparison of Different Telepathology Solutions for Primary Frozen Section Diagnostic

Autor: P. Hufnagl, G. Bayer, P. Oberbarnscheidt, K. Wehrstedt, H. Guski, S. Hauptmann, M. Dietel

Publikováno v: Analytical Cellular Pathology, Vol 21, Iss 3-4, Pp 161-167 (2000)

In a retrospective study on a set of 125 cases we compared the following three telepathology solutions for primary frozen section diagnosis: ATM‐TP (connection via ATM), TPS 1.0 (connection via LAN) and TELEMIC (connection via Internet), which repr

Externí odkaz: https://doaj.org/article/20a0b109e4184a008bed9bf532752781

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

ALK-Testing in non-small cell lung cancer (NSCLC): Immunohistochemistry (IHC) and/or fluorescence in-situ Hybridisation (FISH)?: Statement of the Germany Society for Pathology (DGP) and the Working Group Thoracic Oncology (AIO) of the German Cancer Society e.V. (Stellungnahme der Deutschen Gesellschaft für Pathologie und der AG Thorakale Onkologie der Arbeitsgemeinschaft Onkologie/Deutsche Krebsgesellschaft e.V.)

Autor: M, von Laffert, P, Schirmacher, A, Warth, W, Weichert, R, Büttner, R M, Huber, J, Wolf, F, Griesinger, M, Dietel, Ch, Grohé

Publikováno v: Lung cancer (Amsterdam, Netherlands). 103

The EML4-ALK pathway plays an important role in a significant subset of non-small cell lung cancer patients. Treatment options such as ALK tyrosine kinase inhibitors lead to improved progression free survival and overall survival. These therapeutic o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::f41f423bd81c39a8ed116fad7da24ef5
https://pubmed.ncbi.nlm.nih.gov/28024689

Zobrazit plný text záznamu

[Subgroup Analysis of the Non-interventional REASON Study: PFS and OS According to Age, Smoking History, Gender, and Histology in NSCLC Patients Treated with Gefitinib or Chemotherapy]

Autor: W, Schuette, W E E, Eberhardt, C, Waller, P, Schirmacher, M, Dietel, U, Zirrgiebel, S, Radke, M, Thomas

Publikováno v: Pneumologie (Stuttgart, Germany). 70(9)

Assessment of several clinical factors on progression-free (PFS) and overall survival (OS) in NSCLC patients (pts.) (stage IV) with mutated epidermal growth factor receptor (EGFRm+) treated with gefitinib (gef) or with chemotherapy (CT) under real-wo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::b4701817e7126527aba87a7a5884ad72
https://pubmed.ncbi.nlm.nih.gov/27603946

Zobrazit plný text záznamu

[Exon-dependent Subgroup-analysis of the Non-interventional REASON-Study: PFS and OS in EGFR-mutated NSCLC Patients Treated with Gefitinib or Chemotherapy]

Autor: W, Schuette, M, Dietel, M, Thomas, W, Eberhardt, F, Griesinger, U, Zirrgiebel, S, Radke, P, Schirmacher

Publikováno v: Pneumologie (Stuttgart, Germany). 70(8)

To analyze the influence of the localization of mutations in the epidermal growth factor receptor (EGFR) gene on progression-free (PFS) and overall survival (OS) in patients (pts) with locally advanced or metastatic non-small cell lung cancer (NSCLC)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::acf65019d7ceae0e89c4c12402a6ce34
https://pubmed.ncbi.nlm.nih.gov/27512931

Zobrazit plný text záznamu

[HER2 testing in gastric cancer : Results of a meeting of German experts]

Autor: G, Baretton, M, Dietel, T, Gaiser, T, Kirchner, H H, Kreipe, A, Quaas, C, Röcken, J, Rüschoff, A, Tannapfel, F, Lordick, S, Al-Batran, R, Hofheinz, S, Lorenzen, M, Moehler, P, Thuss-Patience

Publikováno v: Der Pathologe. 37(4)

Valid HER2 testing is essential for the optimal care of patients with HER2-positive gastric cancer and the correct use of first-line treatment. Although all cases of breast cancer are routinely tested for the HER2 status, HER2 testing in gastric canc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::7625c8e4d4479d55acaeb38f7a2ddd94
https://pubmed.ncbi.nlm.nih.gov/27376648

Zobrazit plný text záznamu

[Statement of the German Society for Pathology and the working group thoracic oncology of the working group oncology/German Cancer Society on ALK testing in NSCLC: Immunohistochemistry and/or FISH?]

Autor: M, von Laffert, P, Schirmacher, A, Warth, W, Weichert, R, Büttner, R M, Huber, J, Wolf, F, Griesinger, M, Dietel, C, Grohé

Publikováno v: Der Pathologe. 37(2)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::d486a2cea43cb9abc87165428818696c
https://pubmed.ncbi.nlm.nih.gov/26984297

Zobrazit plný text záznamu

[ALK-Diagnostics in NSCLC - Immunohistochemistry (IHC) and/or Fluorescence-in-situ Hybridisation (FISH)]

Autor: M, von Laffert, P, Schirmacher, A, Warth, W, Weichert, R, Büttner, R M, Huber, J, Wolf, F, Griesinger, M, Dietel, Ch, Grohé

Publikováno v: Pneumologie (Stuttgart, Germany). 70(4)

The EML4-ALK pathway plays an important role in a significant subset of non-small cell lung cancer patients. Treatment options such as tyrosine kinase inhibitors directed against the EML4-ALK signalling pathway lead to improved progression free and o

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::e3316fd738a8f65bbc7d24c83b84914e
https://pubmed.ncbi.nlm.nih.gov/26984109

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání